ArticleCancer medicine2023

Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.

Fenglin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.